日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial

局部晚期或转移性肉瘤患者肿瘤内注射溶瘤病毒 OH2:一项 1/2 期试验

Zhichao Tan #, Yan Wu #, Zhengfu Fan, Tian Gao, Sijuan Ding, Liang Han, Suxia Luo, Qingxia Fan, Jianhua Shi, Chujie Bai, Ruifeng Xue, Shu Li, Lu Zhang, Xinyu Wang, Ling Jia, Lixin Zhou, Binlei Liu, Jing Huang, Jiayong Liu1

Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study

Pucotenlimab 治疗晚期错配修复缺陷或微卫星不稳定性高的实体瘤患者:一项多中心 2 期研究

Bo Zhang, Yan Song, Suxia Luo, Xianli Yin, Enxiao Li, Hui Wang, Yifu He, Zhihui Liu, Qingxia Fan, Xinjun Liang, Yongqian Shu, Yunpeng Liu, Nong Xu, Shu Zhang, Zhixiang Zhuang, Jingdong Zhang, Xiaoge Kou, Fen Wang, Xiaodong Zhu, Shan Zeng, Ke Wang, Haijun Zhong, Shengmian Li, Yuxian Bai, Junyan Yu, Y

Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma

阿帕替尼抑制肿瘤进展并增强细胞毒药物在食管鳞状细胞癌中的抗肿瘤功效

Yanyan Chi, Feng Wang, Yana Zhang, Zhengzheng Shan, Weili Tao, Yujin Lian, Dao Xin, Qingxia Fan, Yan Sun

Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study

拉罗替尼对表皮生长因子受体过度表达或扩增的晚期和既往接受过治疗的食管鳞状细胞癌患者的疗效:一项开放标签、多中心 1b 期研究

Rongrui Liu, Lianke Liu, Chuanhua Zhao, Yuxian Bai, Yulong Zheng, Shu Zhang, Ning Li, Jianwei Yang, Qingxia Fan, Xiuwen Wang, Shan Zeng, Yingjun Zhang, Weihong Zhang, Yulei Zhuang, Ning Kang, Yingzhi Jiang, Hongmei Sun, Jianming Xu4

miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo

miR-135a通过Hedgehog信号通路靶向Smo抑制食管癌干细胞侵袭和迁移

Chengliang Yang, Xiaoli Zheng, Ke Ye, Yanan Sun, Yufei Lu, Qingxia Fan, Hong Ge

MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway

MicroRNA-125a-5p通过抑制STAT3信号通路激活增强食管鳞状细胞癌细胞对顺铂的敏感性

Yan Zhao, Ke Ma, Shujun Yang, Xiaosan Zhang, Feng Wang, Xiaqing Zhang, Hongtao Liu, Qingxia Fan

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer

MicroRNA-29a 可作为肿瘤抑制因子,并通过靶向肺癌中的 NRAS 来增加顺铂敏感性

Xin Liu, Xianping Lv, Qiankun Yang, Huifang Jin, Wenpeng Zhou, Qingxia Fan

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin

二甲双胍在体内和体外抑制食管鳞状细胞癌增殖并增强顺铂的抗癌作用

Feng Wang, Xianfei Ding, Tao Wang, Zhengzheng Shan, Jun Wang, Shaoxuan Wu, Yanyan Chi, Yana Zhang, Zhuan Lv, Liuxing Wang, Qingxia Fan

Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosis

胰岛素生长因子结合蛋白 2 介导淋巴管平滑肌瘤病的进展

Xiangke Li, Xiaolei Liu, Linda Zhang, Chenggang Li, Erik Zhang, Wang Ma, Qingxia Fan, Jane J Yu

Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer

前列腺癌中DNMT1、GSTP1和APC表达及甲基化状态相关性及临床意义

Weijie Zhang, Hongliang Jiao, Xudong Zhang, Ruihua Zhao, Feng Wang, Wei He, Hong Zong, Qingxia Fan, Liuxing Wang